Hyperlipidemia is one of the major risk factor for the development of cardiovascular disease.
Hypolipidemic nutraceuticals and functional foods help improve serum lipid profiles as …

Cardiovascular disease (CVD) is the most common non-communicable ailment which
claims one-third of total global death. This contribution provides an overview of …

Hyperlipidemia is an abnormality of lipid metabolism, characterized by an elevation of total
cholesterol, triglyceride, and low density lipoprotein-cholesterol, and/or a decreasing of high …

Background Hyperlipidemia, characterized by abnormal lipid metabolism, is a dominant
feature of many chronic diseases, including obesity, diabetes, and cardiovascular and …

Nutraceuticals and functional foods are considered useful tools in the management of
moderate plasmatic cholesterol levels. Natural compounds derived from plant, animal, or …

Hyperlipidemia, a chronic disorder of abnormal lipid metabolism, can induce obesity,
diabetes, and cardiovascular and cerebrovascular diseases such as coronary heart disease …

Dyslipidaemia is characterized by increased blood levels of total or LDL cholesterol and
triglycerides, or decreased HDL cholesterol levels, and is a risk factor for cardiovascular …

Dyslipidaemia accelerates the atherosclerotic process and its morbid consequences; statins
represent the evidence-based treatment of choice for reducing low-density lipoprotein …

Nutraceuticals are food components or active ingredients present in foods and used in
therapy. This article analyzes the characteristics of the molecules with a lipid-lowering effect …

Epidemiological studies have demonstrated that elevated levels of plasma total cholesterol
(TC) and low-density lipoprotein cholesterol (LDL-C) are the major risk factors for coronary …